Rachel Riechelmann (@rachelriechelm2) 's Twitter Profile
Rachel Riechelmann

@rachelriechelm2

Clin Oncology Director-AC Camargo Cancer Canter 🇧🇷focus: neuroendocrine tumors, colorectal/anal cancer. Love animals, travels, research. All are born equal.

ID: 1147280863039819777

calendar_today05-07-2019 23:07:27

1,1K Tweet

1,1K Followers

152 Following

Rachel Riechelmann (@rachelriechelm2) 's Twitter Profile Photo

I am very honored to be nominated for Director of Membership of ESMO - Eur. Oncology Election. 😊 the President’s call: #ESMOMembers vote for leaders who’ll shape ESMO’s future. Vote for Directors of Education, Public Policy & Membership , and Chair and members of the Nomination Committee

I am very honored to be nominated for Director of Membership of <a href="/myESMO/">ESMO - Eur. Oncology</a> Election. 😊

the President’s call: 
 #ESMOMembers vote for leaders who’ll shape ESMO’s future. Vote for Directors of Education, Public Policy &amp; Membership , and Chair and members of the Nomination Committee
Van Morris, MD (@vanmorrismd) 's Twitter Profile Photo

❔ ctDNA detection is PROGNOSTIC for inferior outcomes following resection of stage III colon cancer, but is treating more aggressively better? ‼️ NO improvement in RFS by escalating treatment with a ctDNA-informed approach. Congrats to DYNAMIC-III study team for highly

❔ ctDNA detection is PROGNOSTIC for inferior outcomes following resection of stage III colon cancer, but is treating more aggressively better?

‼️ NO improvement in RFS by escalating treatment with a ctDNA-informed approach. Congrats to DYNAMIC-III study team for highly
Pramesh CS (@cspramesh) 's Twitter Profile Photo

Wonderful to see this out in the NEJM today. Structured exercise improves survival in colon cancer! Do come to see #ChrisBooth present in hall B1 at 4 30 PM today ASCO nejm.org/doi/full/10.10…

Wonderful to see this out in the <a href="/NEJM/">NEJM</a> today. Structured exercise improves survival in colon cancer! Do come to see #ChrisBooth present in hall B1 at 4 30 PM today <a href="/ASCO/">ASCO</a> 
nejm.org/doi/full/10.10…
JAMA Oncology (@jamaonc) 's Twitter Profile Photo

Phase 3 oncology RCTs often report positive results based on alternative end points, but actual improvements in overall survival or quality of life are rare, highlighting need to prioritize these outcomes in future research & regulatory processes. #ASCO25 ja.ma/3FCoVHI

Phase 3 oncology RCTs often report positive results based on alternative end points, but actual improvements in overall survival or quality of life are rare, highlighting need to prioritize these outcomes in future research &amp; regulatory processes. #ASCO25 ja.ma/3FCoVHI
JAMA Oncology (@jamaonc) 's Twitter Profile Photo

Most viewed this week from JAMA Oncology: Viewpoint discusses how "skimming the median" can exaggerate survival gains in clinical trials, underscoring the need to critically evaluate Kaplan-Meier curves alongside hazard ratios. ja.ma/45zBluy

Most viewed this week from <a href="/JAMAOnc/">JAMA Oncology</a>: 

Viewpoint discusses how "skimming the median" can exaggerate survival gains in clinical trials, underscoring the need to critically evaluate Kaplan-Meier curves alongside hazard ratios. 

ja.ma/45zBluy
Mairead G McNamara (@mgmcnamara) 's Twitter Profile Photo

Promise of ABBV-706 (SEZ6 targeting ADC; highly expressed in NENs) in refractory high grade NENS: ORR 33.3%, PFS 6.8mo in G3 NET (N=6), ORR 23.1% & PFS 5.45mo in GEP NEC (N=13) #Alissa Cooper #ASCO25 ASCO Neuroendocrine Cancer UK #NotJustNECancer on-going studies awaited.

Promise of ABBV-706 (SEZ6 targeting ADC; highly expressed in NENs) in refractory high grade NENS: ORR 33.3%, PFS 6.8mo in G3 NET (N=6), ORR 23.1% &amp; PFS 5.45mo in GEP NEC (N=13) #Alissa Cooper #ASCO25 <a href="/ASCO/">ASCO</a> <a href="/ncukcharity/">Neuroendocrine Cancer UK #NotJustNECancer</a> on-going studies awaited.
Erika Ruiz-Garcia (@betzabe100) 's Twitter Profile Photo

#ASCO25 last but not least Rodrigo Dienstmann_MD_MBA Frederick Chite MD FASCO we talk about Scalable and Sustainable Innovation in Global Oncology in LMIC & HIC. Global economic cost of cancer will reach USD$25.2 trillions between 20220-25 Instituto Nacional de Cancerología education is key!!

#ASCO25 last but not least <a href="/rdienstmann/">Rodrigo Dienstmann_MD_MBA</a> <a href="/ChiteDoc/">Frederick Chite MD FASCO</a> we talk about Scalable and Sustainable Innovation in Global Oncology in LMIC &amp; HIC. Global economic cost of cancer will reach USD$25.2 trillions between 20220-25 <a href="/incanMX/">Instituto Nacional de Cancerología</a> education is key!!
ESMO - Eur. Oncology (@myesmo) 's Twitter Profile Photo

On #WorldEnvironmentDay, ESMO stands w/ the global community to #BeatPlasticPollution. #Microplastics are found in organs and tumours. More research needed to understand their role in cancer development Pawel Sobczuk 🔗 ow.ly/Q8xT50W3VCP #ESMODailyReporter

On #WorldEnvironmentDay, ESMO stands w/ the global community to #BeatPlasticPollution. #Microplastics are found in organs and tumours. More research needed to understand their role in cancer development 
<a href="/pawel_sobczuk/">Pawel Sobczuk</a>

🔗 ow.ly/Q8xT50W3VCP 

#ESMODailyReporter
Lillian Siu (@lillian_siu) 's Twitter Profile Photo

Please beware that there are fake X accounts using my name for alternate therapies - I do not prescribe any such therapies and I also do not offer medical opinions on X.

Common Sense Oncology (@csoncol) 's Twitter Profile Photo

Join us for a special CSO webinar on June 19 where we discuss some important takeaways from #ASCO25, CSO style. Registration link: queensu.zoom.us/meeting/regist…

Join us for a special CSO webinar on June 19 where we discuss some important takeaways from #ASCO25, CSO style. 
Registration link: queensu.zoom.us/meeting/regist…
BMJ Oncology (@bmjoncology) 's Twitter Profile Photo

Too many women with Lynch syndrome are still being missed because they're not referred for definitive blood testing in a timely way. Read the new study: bmjoncology.bmj.com/content/4/1/e0…

Too many women with Lynch syndrome are still being missed because they're not referred for definitive blood testing in a timely way. 

Read the new study: bmjoncology.bmj.com/content/4/1/e0…
Rachel Riechelmann (@rachelriechelm2) 's Twitter Profile Photo

Thank you to all colleagues who voted in the 2025 #ESMO election I'm honored to announce that I was elected as Director of Membership 😊 my aim is to extend ESMO - Eur. Oncology benefits to much more members across the globe!

Arndt Vogel (@arndtvogel) 's Twitter Profile Photo

Outcomes of Solid Organ Transplant Recipients With Advanced Cancers Receiving Immune Checkpoint Inhibitors JAMA Oncology doi.org/10.1001/jamaon… 🔎128 studies, 343 SOTRs 👉Acute rejection: 36.2%; graft loss: 18%, lower risk w/ steroids & mTOR 👉ORR: 31% 🧐ICI my be considered in

Outcomes of Solid Organ Transplant Recipients With Advanced Cancers Receiving Immune Checkpoint Inhibitors
<a href="/JAMAOnc/">JAMA Oncology</a> 
doi.org/10.1001/jamaon…
🔎128 studies, 343 SOTRs
👉Acute rejection: 36.2%; graft loss: 18%, lower risk w/ steroids &amp; mTOR
👉ORR: 31%
🧐ICI my be considered in
Angela Lamarca (@drangelalamarca) 's Twitter Profile Photo

Poorly Differentiated Neuroendocrine Carcinomas - by Garcia-Carbonero's Lab at ESMO - Eur. Oncology #ESMOGI25 👉Poorly dif 👉High Ki67 👉Agressive 🏥Chemo ASAP (PlatinumEtoposide) ✅FDG-PET (⛔️SSTR; 28% would to a Ga-PET 😫) 🤞🏻IO promising #ESMOAmbassadors Rachel Riechelmann Juan OConnor

Poorly Differentiated Neuroendocrine Carcinomas - by <a href="/GCarboneroLab/">Garcia-Carbonero's Lab</a> at <a href="/myESMO/">ESMO - Eur. Oncology</a> #ESMOGI25

👉Poorly dif
👉High Ki67
👉Agressive

🏥Chemo ASAP (PlatinumEtoposide)
✅FDG-PET (⛔️SSTR; 28% would to a Ga-PET 😫)
🤞🏻IO promising

#ESMOAmbassadors <a href="/RachelRiechelm2/">Rachel Riechelmann</a> <a href="/Juanmaoconnor/">Juan OConnor</a>
Dr. Cathy Eng (@cathyengmd) 's Twitter Profile Photo

Small @myesmo #ESMOGI25 reunion in the faculty room! Great way to start the AM. Some of my fave people: Dr. Eileen O’Reilly, Angela Lamarca and Karyn Goodman, MD, MS ☹️Missed our photo 📸opportunity with Rachel Riechelmann! #ESMOAmbassadors #cancer #CancerResearch

Small @myesmo #ESMOGI25 reunion in the faculty room! Great way to start the AM.  Some of my fave people:   Dr. Eileen O’Reilly, <a href="/DrAngelaLamarca/">Angela Lamarca</a> and <a href="/KarynAGoodman/">Karyn Goodman, MD, MS</a> 

☹️Missed our photo 📸opportunity with <a href="/RachelRiechelm2/">Rachel Riechelmann</a>! 

#ESMOAmbassadors #cancer #CancerResearch